Control group Cpk Cpa   χ2 p OR 95%CI
ERCC4rs3136176 / ERCC4rs1799798
A A 45.89 (0.111) 13.00 (0.197) 23.99 (0.133) Cpkvs.Cpa Cpkvs. Control group Cpavs. Control group 1.534 3.854 0.575 0.215556 0.049650 0.448350 0.627 1.956 1.226 0.2981.319 0.991 – 3.861 0.7232.080
A G 267.11 (0.645) 37.00 (0.561) 102.01 (0.567) Cpkvs.Cpa Cpkvs. Control group Cpavs. Control group 0.007 1.899 3.564 0.931129 0.168200 0.059054 1.025 0.692 0.709 0.5811.810 0.408 – 1.171 0.496 – 1.014
T G 98.89 (0.239) 16.00 (0.242) 53.99 (0.300) Cpkvs.Cpa Cpkvs. Control group Cpavs. Control group 0.785 0.002 2.343 0.375562 0.967137 0.125836 1.339 1.013 1.356 0.7012.557 0.552 – 1.858 0.917 – 2.005
T A 2.11 (0.005) 0.00 (0.000) 0.01 (0.000) Cpkvs.Cpa Cpkvs. Control group Cpavs. Control group – – – – – – – – – – – –
Total control group= 414.0, total Cpk= 66.0, total Cpa=180.0 Cpkvs.Cpa: χ2Global= 1.868017, df= 2 (frequency <0.03 in both Cpk&Cpa has been dropped), p= 0.392975 Cpk vs. control group: χ2Global= 4.070642, df= 2 (frequency <0.03 in both Cpk& control group has been dropped), p= 0.130639 Cpa vs. control group: χ2Global= 3.586152, df= 2 (frequency <0.03 in both Cpa& control group has been dropped), p= 0.166447
Table 6: ERCC4rs3136176 and ERCC4rs1799798 haplotype in cervical squamous cell carcinoma (CSCC): carcinoma planoepitheliale keratodes (Cpk), and carcinoma planoepitheliale aceratodes (Cpa) and healthy women.